Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

SHE:300519 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	56.04	54.21	50.39	64.36	108.82	114.28
Depreciation & Amortization	14.74	14.74	14.93	14.77	14.05	12.86
Loss (Gain) From Sale of Assets	0	0	0.07	0.29	-	0.71
Asset Writedown & Restructuring Costs	0.04	0.04	0.01	-0.02	-0	0.49
Loss (Gain) From Sale of Investments	-5.63	-5.63	-4.87	-4.07	-4.32	-6.42
Provision & Write-off of Bad Debts	-0.2	-0.2	0.11	-0.71	0.43	-
Other Operating Activities	8.59	0.44	0.39	0.5	0.2	-
Change in Accounts Receivable	4.93	4.93	-2.69	14.4	-8.44	2.93
Change in Inventory	25.63	25.63	1.69	-25.78	0.42	-4.46
Change in Accounts Payable	-25.44	-25.44	-6.55	-10.6	15.37	22.02
Operating Cash Flow	78.9	68.92	53.43	53.29	126.43	142.36
Operating Cash Flow Growth	39.93%	28.99%	0.27%	-57.85%	-11.19%	26.41%
Capital Expenditures	-2.69	-3.48	-5.2	-15.99	-16.64	-14.71
Sale of Property, Plant & Equipment	0.01	0.03	0.1	0.32	0.03	0.2
Investment in Securities	-208.12	-215	-30	-40	10	-36.8
Other Investing Activities	41.14	5.94	5.14	4.29	4.55	6.78
Investing Cash Flow	-169.66	-212.5	-29.96	-51.37	-2.07	-44.54
Common Dividends Paid	-48	-48	-64	-80	-96	-96
Financing Cash Flow	-48	-48	-64	-80	-96	-96
Net Cash Flow	-138.76	-191.58	-40.53	-78.08	28.36	1.82
Free Cash Flow	76.21	65.45	48.23	37.3	109.78	127.64
Free Cash Flow Growth	42.23%	35.69%	29.30%	-66.02%	-13.99%	24.72%
Free Cash Flow Margin	29.25%	24.66%	18.02%	13.80%	31.23%	39.78%
Free Cash Flow Per Share	0.48	0.41	0.30	0.23	0.69	0.79
Cash Income Tax Paid	33.08	33.59	23.4	44.9	36	44.76
Levered Free Cash Flow	60.63	45.19	23.2	7.05	71.83	87.81
Unlevered Free Cash Flow	60.63	45.19	23.2	7.05	71.83	87.81
Change in Working Capital	5.33	5.33	-7.59	-21.83	7.24	20.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.